Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling

Nicholas R. Anderson(University of Alabama at Birmingham), Ravi Bhatia(University of Alabama at Birmingham), Robert S. Welner(Harvard University), Puneet Agarwal(University of Alabama at Birmingham), Shaowei Qiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Mason W Harris(University of Alabama at Birmingham), David K. Crossman(University of Alabama at Birmingham), Vipul Sheth(University of Alabama at Birmingham), Takashi Nagasawa(The University of Osaka), Hui Li(Shanghai Stomatological Hospital), Andrew J. Paterson, Harish Kumar(University of Alabama at Birmingham)
Leukemia
December 22, 2022
10.1038/s41375-022-01798-5
Cited by 31

Related Papers

CO2 regulator SLAC1 and its homologues are essential for anion homeostasis in plant cells
|Nature|2008|628
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
|Blood|2003|541
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
|Journal of Clinical Oncology|2013|473